Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration
Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration
The objective is to assess a compact, portable, wireless movement disorder system with
 continuous monitoring capabilities to detect and quantify the severity of levodopa-induced
 dyskinesia in Parkinson's disease.
Inclusion Criteria:

 -  Diagnosis of idiopathic Parkinson's disease

 -  Clinical history of levodopa-induced dyskinesia

 -  21 Years of age or older

 -  Stage 2 - 4 OFF-medication on the Hoehn and Yahr scale

 Exclusion Criteria:

 -  Dementia (determined by a neuropsychological assessment)

 -  Severe tremor unaffected by levodopa